NYSCF Vice President of research and development, Stephen Chang, PhD, participated on a panel exploring stem cell research and the potential induced pluripotent cells hold for future research for a webinar series on innovative cell research for The Scientist on September 18th.
NYSCF Scientist Dieter Egli, PhD, spoke about cell fate control, specifically with regard to his work on genome exchange in human oocytes, at the International Society for Stem Cell Research regional forum. This forum, held in Florence, Italy focused on stem cells in translation and ran from September 15th through 18th.
NYSCF CEO Susan Solomon recently sat down with NYC Tech Connect Blogger Howard Johnson to talk about NYSCF's mission, research model, how NYSCF fits within the New York biotech community and where she sees the future of collaboration and stem cell research.
NYSCF researchers Dr. Giuseppe Maria de Peppo and Dr. Darja Marolt published a review article in Stem Cell Research & Therapy on how modifying the human iPS cell culture environment has the potential for improving construction of various stem cell-derived tissue substitutes. Dr. de Peppo, a NYSCF Research Fellow, focuses mainly on use of human iPS cells to engineer vascularized bone to study its potential use in treatment and new bone-regeneration therapies.
Only a small portion of genes is active in a cell at any one time. Special molecules, known as methyl markers, help regulate certain genes, playing an essential role in cell development and identity. Significantly, diseased and healthy cells differ in where these markers are added to DNA, which, in turn, affects gene expression. Alex Meissner, PhD, a NYSCF — Robertson Stem Cell Investigator at the Broad Institute of MIT and Harvard, and his team charted the methylation patterns across the full genome of 30 cells, including adult healthy or diseased cells and stem cells. He found that the quantity and pattern of methyl markers differed by cell types. As researchers try to identify early-stage indicators of disease, this methylation map could be an important tool.
David Patrick Columbia sat down with Susan L. Solomon, CEO of NYSCF, to talk about Solomon's journey to founding NYSCF, one of the most advanced stem cell research institutes worldwide.
On July 19, NYSCF Board member Margo Alexander and her husband Bob Alexander opened their home to the most advanced stem cell science, hosting NYSCF's Annual Summer Cocktail Reception. This exciting evening included an address by Susan L. Solomon, research descriptions from NYSCF scientists, and a talk on the NYSCF Global Stem Cell Array by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease.
"The arts and sciences usually exist in two separate worlds, but on Thursday evening The New York Stem Cell Foundation united the two at its first spring benefit at the newly renovated New York Genome Center in SoHo.
"Representing art, Dorothy Lichtenstein, Michael Joaquin Grey, Yigal Ozeri and Donald Sultan sat on a panel alongside NYSCF scientists Valentina Fossati and Scott Noggle."